Carolyn Grove

Search results

• 2022

  Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML)

  Shortt, J., Platzbecker, U., Tan, S. Y., Cannell, P., Ng, T. F., Fong, C. Y., Ramanathan, S., Rajagopal, R., Leitch, S., Gasiorowski, R., Grove, C., Lenton, D., Tan, P., Dinardo, C., Ling, M. T., Cheng, S., Liu, Y., Co, M., Chan, W. Y. & Simpson, D. & 1 others, Wei, A. H., Nov 2022, In: Oncology Research and Treatment. 45, SUPPL 3, p. 144-144 1 p.

  Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review